mRNA |
foretinib |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0006 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0007 |
mRNA |
Irinotecan |
CCLE |
pan-cancer |
AAC |
-0.19 |
0.0007 |
mRNA |
TKI258 |
CCLE |
pan-cancer |
AAC |
0.16 |
0.0008 |
mRNA |
Axitinib |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0008 |
mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0008 |
mRNA |
tivozanib |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.0009 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.0009 |
mRNA |
Cytarabine |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.001 |
mRNA |
AZD8055 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.001 |